Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Review Article

Assessment for Diabetic Neuropathy: Treatment and Neurobiological Perspective

In Press, (this is not the final "Version of Record"). Available online 24 May, 2024
Author(s): Bhanupriya Bhrigu, Shikha Sharma*, Nitin Kumar and Bimal Krishna Banik
Published on: 24 May, 2024

Article ID: e240524230300

DOI: 10.2174/0115733998290606240521113832

Price: $95

Abstract

Diabetic neuropathy, also known as diabetic peripheral sensorimotor neuropathy (DPN), is a consequential complexity of diabetes, alongside diabetic nephropathy, diabetic cardiomyopathy, and diabetic retinopathy. It is characterized by signs and symptoms of peripheral nerve damage in diabetes patients after ruling out other causes. Approximately 20% of people with diabetes are affected by this painful and severe condition. The development of diabetic neuropathy is influenced by factors such as impaired blood flow to the peripheral nerves and metabolic issues, including increased polyol pathway activation, myo-inositol loss, and nonenzymatic glycation. The present review article provides a brief overview of the pathological changes in diabetic neuropathy and the mechanisms and types of DPN. Various diagnostic tests and biomarkers are available to assess nerve damage and its severity. Pharmacotherapy for neuropathic pain in diabetic neuropathy is complex. This review will explore current treatment options and potential future developments to improve the quality of life for patients suffering from diabetic neuropathy.

Keywords: Diabetic neuropathy, mechanism of diabetic neuropathy development, pharmacotherapy polyol pathway, retinopathy, sepsis complications.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy